PUBLISHER: DataM Intelligence | PRODUCT CODE: 1290362
PUBLISHER: DataM Intelligence | PRODUCT CODE: 1290362
The Global Angiographic Catheters Market reached US$ 1,257.3 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 2,229.8 million by 2030. The global angiographic catheters market is expected to exhibit a CAGR of 7.6% during the forecast period (2023-2030). Rapid technical advancements in medical equipment, as well as rising government expenditures for the construction of healthcare infrastructure, are important factors driving the global angiographic catheters market.
Angiographic catheters are extremely important in the fields of interventional cardiology and radiology. These catheters are specialized medical devices that are used to see blood vessels and perform diagnostic and therapeutic treatments.
The rising incidence of cardiovascular conditions such as coronary artery disease, peripheral artery disease, and heart attacks has led to a growing need for diagnostic and interventional procedures. Angiographic catheters are essential tools in performing angiography to visualize and assess blood vessels, aiding in the diagnosis and treatment of these diseases.
Also, technological advancements drive the angiographic market in such a way that it has improved their performance and safety. Innovations such as improved imaging capabilities, better catheter materials, and enhanced maneuverability have made procedures more accurate and minimally invasive, leading to increased adoption and demand for these catheters.
The angiographic catheter market is subject to strict regulatory oversight and compliance with various medical device regulations. Meeting these requirements can increase the time and cost associated with product development and approval.
Reimbursement policies and coverage by insurance providers can impact the adoption of angiographic catheters. If reimbursement rates are low or if certain procedures involving angiographic catheters are not covered, healthcare facilities and providers may be reluctant to invest in these devices or perform the procedures.
The angiographic catheters market was hugely affected by COVID-19 through various factors like decreased procedure volumes. During the pandemic, many hospitals and healthcare facilities experienced a significant reduction in elective procedures, including non-emergency angiographic procedures. This decline in procedure volumes directly affected the demand for angiographic catheters.
Due to the strain on healthcare systems and the need to prioritize resources, there was a shift towards performing angiographic procedures primarily for urgent or emergency cases. This shift reduced the overall utilization of angiographic catheters.
The global supply chain disruptions caused by the pandemic resulted in challenges in the production, distribution, and availability of medical devices, including angiographic catheters. Manufacturing facilities faced temporary closures, transportation restrictions, and shortages of raw materials, leading to delays and supply chain interruptions.
The global angiographic catheters market is segmented based on product type, application and end user.
The scoring balloon catheters segment is expected to hold a substantial share of around 37.2% in the angiography catheter market. Where scoring balloon catheters are used during certain interventional procedures, both scoring balloon catheters and angiography catheters may be used in sequence. For example, during an angioplasty procedure, an angiography catheter is first used to obtain diagnostic images of the affected blood vessels. Once the lesion has been identified, a scoring balloon catheter may be introduced to facilitate lesion modification and optimize vessel dilation.
North America is the dominating region for the angiographic catheters market due to well-developed healthcare infrastructure and a high level of healthcare spending, which further supports the market growth. Technological advancements in angiographic catheters, such as the development of new materials, improved designs, and enhanced imaging capabilities, also contribute to market expansion.
Factors that influence the market for angiographic catheters include the prevalence of cardiovascular diseases, advancements in technology, healthcare infrastructure, and reimbursement policies. North America, particularly the United States, has a significant burden of cardiovascular diseases, which drives the demand for angiographic catheters.
The major global players include: Medtronic, Boston Scientific Corporation, Terumo Medical Corporation, Cardinal Health, Merit Medical Systems, Inc, Abbott, Aachen Resonance Entwicklungsgesellschaft Mbh, Zoll Medical Corporation, Contego Medical, Inc, and Asahi Intecc Co. LTD.
The global angiographic catheters market report would provide approximately 92 tables, 108 figures and 195 pages.
LIST NOT EXHAUSTIVE